IL33 and respiratory system disorder: This review has illuminated the pathways through which IL-33 contributes to respiratory disease development and has explored the mechanisms and feasibility of drugs targeting IL-33.IL-33 activates the ST2 receptor, initiating a cascade of inflammatory responses that drive the progression and aggravation of respiratory diseases.